Artificial Pancreas Device Systems Market Size, Share, Growth, Trends, and Industry Analysis: By Technology, Treat to Target/ Control to Target ), By End User, By Application and Region

Artificial Pancreas Device Systems Market Size, Share, Growth, Trends, and Global Industry Analysis: Size, Share, Growth, Trends, and Industry Analysis By Technology (Threshold Suspended Device Systems, Treat to Range/Control to Range (TTR/CTR), Treat to Target/ Control to Target (TTR/CTT)) , By End User (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres), By Application (Type 1 Diabetic Patients, Type 2 Diabetic Patients) and Region

Artificial Pancreas Device Systems Market size was valued at US$ 97.8 million in 2023 and poised to grow at a CAGR of 12.5% from 2024 to 2030. Artificial pancreas device systems are medical devices which links glucose to an insulin paracetamol infusion pump, monitor reading. These devices are meant to improve glycaemic control in patients with insulin-dependent diabetes and in control of nocturnal hypoglycaemia. The pancreas will secrete insulin and glucagon. Type-I diabetes occurs when the pancreas produces little or none of the insulin needed to regulate blood glucose. Type-II diabetes occurs when the pancreas does not produce enough insulin or the body becomes resistant to insulin that is present. The burgeoning incidence of diabetes is the major factor, which is expected to trigger the artificial pancreas devices market. As per WHO, global diabetes cases were increased from 108 Mn to 422Mn from 1980 to 2014.

As per, Juvenile Diabetes Research Foundation in 2015, around 1.5Mn cases of type-I were found. Furthermore, growing geriatric population, increase in the incidence of lifestyle disorders and obesity which further leads diabetes which in turns propel the growth of artificial pancreas devices market. However, the insulin used in artificial pancreas devices takes the long duration to get absorb, lack of awareness, a dearth of skilled professionals are the factors which are restraining the growth of artificial pancreas device systems market. Favourable regulations, increased collaborations coupled with rising prevalence of diabetes are expected to boost the market. FDA is collaborating with government and private research institutions to enhance the clinical studies and to speed up the development of innovative technologies in artificial pancreas device systems.

Global Artificial Pancreas Device Systems Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.5%

Largest Market

North America

Fastest Growing Market

Europe

Artificial Pancreas Device Systems Market Dynamics

Technological innovations and product developments are propelling the market growth such as Tandem diabetes care outline its plans in APDS market by initiating R&D phase of its artificial pancreas system. Bigfoot Biomedicals goal is to create a pump sensor union therapy which could be much simpler than the current counterparts. Beta bionics developed iLet Bionic Pancreas System which delivers both insulin and glucagon in type-1DM patients. Hence, all these products from the major players will be available soon which could increase the growth of the market.

Global Artificial Pancreas Device Systems Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 97.8 million

Market CAGR

12.5%

By Technology

  • Threshold Suspended Device Systems
  • Treat to Range/Control to Range (TTR/CTR)
  • Treat to Target/ Control to Target (TTR/CTT)

By End User

  • Hospitals
  • Diagnostic centres
  • Ambulatory surgical centres

By Application

  • Type 1 Diabetic Patients
  • Type 2 Diabetic Patients

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Features of the Report

  • The artificial pancreas device system market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The artificial pancreas device systems market size was valued at US$ 97.8 million in 2023 and poised to grow at a CAGR of 12.5% from 2024 to 2030.

Increasing Prevalence of Diabetes

Europe is the fastest-growing for the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Artificial Pancreas Device Systems Market Introduction 
2.1.Global Artificial Pancreas Device Systems Market  - Taxonomy
2.2.Global Artificial Pancreas Device Systems Market  - Definitions
2.2.1.Technology
2.2.2.End User
2.2.3.Application
2.2.4.Region
3.Global Artificial Pancreas Device Systems Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Artificial Pancreas Device Systems Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Artificial Pancreas Device Systems Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Threshold Suspended Device Systems
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Treat to Range/Control to Range (TTR/CTR)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Treat to Target/ Control to Target (TTR/CTT)
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Artificial Pancreas Device Systems Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Diagnostic centres
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ambulatory surgical centres
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Artificial Pancreas Device Systems Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Type 1 Diabetic Patients
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Type 2 Diabetic Patients
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Artificial Pancreas Device Systems Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Artificial Pancreas Device Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Threshold Suspended Device Systems
9.1.2.Treat to Range/Control to Range (TTR/CTR)
9.1.3.Treat to Target/ Control to Target (TTR/CTT)
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Diagnostic centres
9.2.3.Ambulatory surgical centres
9.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Type 1 Diabetic Patients
9.3.2.Type 2 Diabetic Patients
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Artificial Pancreas Device Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Threshold Suspended Device Systems
10.1.2.Treat to Range/Control to Range (TTR/CTR)
10.1.3.Treat to Target/ Control to Target (TTR/CTT)
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Diagnostic centres
10.2.3.Ambulatory surgical centres
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Type 1 Diabetic Patients
10.3.2.Type 2 Diabetic Patients
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Artificial Pancreas Device Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Threshold Suspended Device Systems
11.1.2.Treat to Range/Control to Range (TTR/CTR)
11.1.3.Treat to Target/ Control to Target (TTR/CTT)
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Diagnostic centres
11.2.3.Ambulatory surgical centres
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Type 1 Diabetic Patients
11.3.2.Type 2 Diabetic Patients
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Artificial Pancreas Device Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Threshold Suspended Device Systems
12.1.2.Treat to Range/Control to Range (TTR/CTR)
12.1.3.Treat to Target/ Control to Target (TTR/CTT)
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Diagnostic centres
12.2.3.Ambulatory surgical centres
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Type 1 Diabetic Patients
12.3.2.Type 2 Diabetic Patients
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Artificial Pancreas Device Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Threshold Suspended Device Systems
13.1.2.Treat to Range/Control to Range (TTR/CTR)
13.1.3.Treat to Target/ Control to Target (TTR/CTT)
13.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Hospitals
13.2.2.Diagnostic centres
13.2.3.Ambulatory surgical centres
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Type 1 Diabetic Patients
13.3.2.Type 2 Diabetic Patients
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.MEDTRUM TECHNOLOGIES (UK)
14.2.2.Medtronic (U.S)
14.2.3.Tandem Diabetes Care, Inc. (U.S)
14.2.4.Beta Bionics (U.S)
14.2.5.Johnson & Johnson (U.S)
14.2.6.Insulet Corporation (U.S)
14.2.7.Bigfoot Biomedical, INC.(U.S).
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • MEDTRUM TECHNOLOGIES (UK)
  • Medtronic (U.S)
  • Tandem Diabetes Care, Inc. (U.S)
  • Beta Bionics (U.S)
  • Johnson & Johnson (U.S)
  • Insulet Corporation (U.S)
  • Bigfoot Biomedical, INC.(U.S).

Related Industry Reports